Citation: | CAO Feng, MA Yunan. Thoughts on current chemistry, manufacturing & control(CMC)technical review requirement of chemical active pharmaceutical ingredients[J]. Journal of China Pharmaceutical University, 2014, 45(3): 274-280. DOI: 10.11665/j.issn.1000-5048.20140304 |
[1] |
Chen Z.Progress of CMC technical requirements for registration of chemical drugs in China[J].Chin New Drugs J(中国新药杂志),2014,23(1):20-24.
|
[2] |
China Food and Drug Administration.2012 China drug review annual report[J].Chin New Drugs J(中国新药杂志),2013,22(6):611-616.
|
[3] |
Chen Z.Study on related substances and new drug application[J].Chin J Pharma(中国医药工业杂志),2010,4(11):872-876.
|
[1] | LIANG Jinlai, XU Wei, YIN Tingjie, HUO Meirong. Advances in the hypoxia-responsive antitumor drug nanocarriers and tumor hypoxia relieve[J]. Journal of China Pharmaceutical University, 2018, 49(3): 255-262. DOI: 10.11665/j.issn.1000-5048.20180301 |
[2] | GUO Yahui, LU Peng, WANG Yubin, ZHANG Huibin. Progress in the researches for antitumor NEDD8 activating enzyme inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603 |
[3] | GAO Yahan, PING Qineng, ZONG Li. Preparation and antitumor activity of mitoxantrone conjugated D-α-tocopherylpolyethylene glycol 1000 succinate prodrug micelle[J]. Journal of China Pharmaceutical University, 2016, 47(3): 311-316. DOI: 10.11665/j.issn.1000-5048.20160311 |
[4] | LIU Yan, WANG Tingting, CHEN Li. Synthesis and antitumor activity of isosteviol derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(1): 48-53. DOI: 10.11665/j.issn.1000-5048.20160106 |
[5] | LIU Wenhu, CHANG Jinxia, ZHANG Jianwu. Synthesis and antitumor activities of novel coumarin derivatives containing chalcone moiety[J]. Journal of China Pharmaceutical University, 2014, 45(5): 522-528. DOI: 10.11665/j.issn.1000-5048.20140503 |
[6] | CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206 |
[7] | LI Linhu, CHEN Li, XIA Yufeng. Progress in the study of coumarin derivatives as antitumor agents[J]. Journal of China Pharmaceutical University, 2013, 44(4): 374-379. DOI: 10.11665/j.issn.1000-5048.20130417 |
[8] | JIN Hui, LIU Lifeng, DENG Weiping, LIU Jianwen. Antitumor effects and molecular mechanisms of novel selective HDAC inhibitors in human cervix carcinoma HeLa cells[J]. Journal of China Pharmaceutical University, 2013, 44(4): 352-356. DOI: 10.11665/j.issn.1000-5048.20130413 |
[9] | Studies on the Difference in Content of an Antitumor Component 5F in Pteris semipinnata L.[J]. Journal of China Pharmaceutical University, 2002, (5): 48-50. |
[10] | Antitumor Effect of Fu Fang Xiao Liu Wan[J]. Journal of China Pharmaceutical University, 1997, (1): 42-44. |